ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 351

Trabecular Bone Score Is Severely Affected in Male Patients with Chronic Obstructive Pulmonary Disease

Marta Arévalo Salaet1, Enrique Casado Burgos1, M Gallego1, Luis Del Rio2, Marta Larrosa3 and Jordi Gratacos4, 1Hospital Universitari Parc Taulí, Sabadell, Spain, 2CETIR Medical Centre, Terrassa, Spain, 3Rheumatology, Hospital Parc Taulí, Sabadell, Spain, 4Rheumatology, Hospital de Sabadell, Sabadell, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Copd and osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Patients with chronic obstructive pulmonary disease (COPD) have a high risk of osteoporosis and fractures. In a cohort of male patients with COPD we reported 33% of vertebral fractures, with 27% of fractures in patients with normal bone mineral density (BMD)1. Trabecular Bone Score (TBS) has been described as an index of bone microarquitecture, and could be a new assessment tool to detect bone quality impairment in these patients.

Analysis of TBS in a sub-cohort of male patients with COPD and its possible association with BMD, corticoid use, COPD severity or vertebral fractures.

1Casado E, et al. JBMR 2007; 22 (S1): S202.

Methods:

Male patients, older than 50 years, with COPD defined according to ATS/ERS classification (FEV1/FVC<70%) were included. Exclusion criteria: Other concomitant pulmonary disease, rheumatologic and/or vertebral disease that may lead to missinterpretation of BMD by DXA. BMD was determined by dual-energy X-ray absorptiometry (DXA) at lumbar spine and proximal femur. Vertebral fractures were assessed by thoracic and lumbar X-ray. Corticosteroid use in the previous five years and number of hospitalizations were recorded in all patients.

 

Results:

We included 98 patients. Mean age 67.8±7.5 years. 38% patients had a mild pulmonar disease, 39% moderate and 23% had a severe disease ((FEV1/FVC<30%). 29 patients (30%) had morphometric vertebral fractures. Mean BMD T-score at lumbar spine -1.67±1.55, at femoral neck -1.81±1.04, and al total hip -1.31±1.14. Mean TBS was 1.035±0,135 (T-score -2.85±1.18). TBS was lower in fractured patients (T -2.59±1.16 vs -2.34±1.22; p=NS). According to COPD severity TBS was lower in patients with modereate disease (T-2.57±1.34) and severe disease (T -2.54±1.34) than in patients with mild disease (T -2.19±1.32), although without reaching significant differences. We didn’t find  any significant assotiation between TBS and corticosteroid use.

Conclusion:

TBS is severely affected in male patients with chronic obstructive pulmonary disease, especially in patients with moderate and severe pulmonar disease. Low TBS seems to be associated with vertebral fractures in this population.


Disclosure: M. Arévalo Salaet, None; E. Casado Burgos, None; M. Gallego, None; L. Del Rio, None; M. Larrosa, None; J. Gratacos, None.

To cite this abstract in AMA style:

Arévalo Salaet M, Casado Burgos E, Gallego M, Del Rio L, Larrosa M, Gratacos J. Trabecular Bone Score Is Severely Affected in Male Patients with Chronic Obstructive Pulmonary Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/trabecular-bone-score-is-severely-affected-in-male-patients-with-chronic-obstructive-pulmonary-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trabecular-bone-score-is-severely-affected-in-male-patients-with-chronic-obstructive-pulmonary-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology